Sharon Klahre is the Vice President of Investor Relations and Strategic Finance at Spero Therapeutics. Prior to joining Spero Therapeutics in 2017, she led Investor Relations at Forward Pharma A/S, a development stage company focused on multiple sclerosis. In addition to serving as a liaison to the investor community, she provides input on financial strategy and has participated in several follow-on financings and IPOs. Ms. Klahre previously spent 10 years in equity research covering small to large cap biotechnology companies at Stifel Financial Corp and Lazard Capital Markets. Prior to her career in equity research, Ms. Klahre worked at Roche Molecular Diagnostics. She received her B.S. in Biology from Lehigh University.